Synthesis, Characterization, and Biological Evaluation of N-Methyl Derivatives of Norbelladine
Molecules · 2024
DOI: 10.3390/molecules29184442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von S Mahsa Hashemian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Biochemistry and Physics, Université du Québec à Trois-Rivières, Trois-Rivières, QC G8Z 4M3, Canada. Hauptthemen laut MEDLINE: Antiviral Agents, Molecular Docking Simulation, Butyrylcholinesterase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Norbelladine derivatives have garnered attention in recent years due to their diverse biological activities and pivotal role in the biosynthetic pathway of Amaryllidaceae alkaloids. This study reports the synthesis and biological evaluation of four O,N-methylated derivatives of norbelladine. These derivatives were synthesized through a three-step process: forming imine intermediates from benzaldehydes with tyramine, hydrogenating them to secondary amines, and N-methylating these amines. The products were purified and characterized by 1H and 13C NMR spectroscopy. Their biological activities were assessed by evaluating their ability to inhibit Alzheimer’s disease-related enzymes acetylcholinesterase and butyrylcholinesterase. Additionally, the cytotoxic activity of the novel derivatives was tested against cancer cell lines derived from hepatocarcinoma (Huh7), adenocarcinoma (HCT-8), and acute myeloid leukemia (THP-1) cells, and their antiviral properties against a human coronavirus (HCoV-OC43), a flavivirus (dengue virus), and a lentivirus (pseudotyped HIV-1). Docking analysis was performed to understand the impact of the N-methylation on their pharmacological relevance. The results indicate that while N-methylation does not significantly affect antiviral activity, it enhances butyrylcholinesterase inhibition for N-methylnorbelladine and 4′-O,N-dimethylnorbelladine. Overall, this work enhances our understanding of norbelladine derivatives, provides new tools for Alzheimer’s disease research, and lays the groundwork for future pharmaceutical developments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Biochemistry and Physics, Université du Québec à Trois-Rivières, Trois-Rivières, QC G8Z 4M3, Canada.
- Department of Chemistry, Université du Québec à Montréal, Montréal, QC H2L 2C4, Canada.
- Department of Medical Biology, Université du Québec à Trois-Rivières, Trois-Rivières, QC G8Z 4M3, Canada.
- Plant Biology Research Group, Trois-Rivières, QC G8Z 4M3, Canada.
ORCID-Profile: Benoit Daoust, Isabel Desgagné-Penix
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Hashemian, S. M., Merindol, N., Paquin, A., Singh, A., Berthoux, L., Daoust, B., & Desgagné-Penix, I. (2024). Synthesis, Characterization, and Biological Evaluation of N-Methyl Derivatives of Norbelladine. Molecules. https://doi.org/10.3390/molecules29184442
Vancouver
Hashemian SM, Merindol N, Paquin A, Singh A, Berthoux L, Daoust B, et al. Synthesis, Characterization, and Biological Evaluation of N-Methyl Derivatives of Norbelladine. Molecules. 2024. doi:10.3390/molecules29184442
BibTeX
@article{Hashemian2024,
author = {Hashemian, S Mahsa and Merindol, Natacha and Paquin, Alexis and Singh, Amita and Berthoux, Lionel and Daoust, Benoit and Desgagné-Penix, Isabel},
title = {Synthesis, Characterization, and Biological Evaluation of N-Methyl Derivatives of Norbelladine},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29184442}
}
EUVIMED